Lexon and Jeff Koons Collaborate to Revolutionize Art with Technology
11.6.2025 08:00:00 CEST | Business Wire | Press Release
Lexon is proud to announce a historic collaboration with Jeff Koons, unveiling the Balloon Dog Speaker and Balloon Dog Lamp: two reimagined, sculptural objects that merge art and technology in an unprecedented way. These official editions envisioned with The Broad in Los Angeles bring the playful spirit of Koons’ iconic art into homes worldwide. Pre-orders for this collection will be available starting June 17, 2025, exclusively on lexon-design.com with limited supply.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610649262/en/
Lexon x Jeff Koons
A Transparent Fusion of Art and Function
The Balloon Dog Speaker and Balloon Dog Lamp expand Jeff Koons’ iconic Balloon Dog into new, everyday objects, using a high-quality translucent material that echoes its signature curves and captivating presence.
Originally conceived in the 1990s, Koons’ Balloon Dog is one of the most recognized symbols of contemporary art. Now, in partnership with Lexon, this masterpiece has been 'inflated' with technology, giving rise to functional and accessible objects. The transformation of Koons’ Balloon Dog into a tech-powered object is a remarkable feat of engineering, with over 50,000 hours dedicated to perfecting every detail.
Conceived as a true acoustic art piece equipped with Bluetooth 5.0 technology, the Balloon Dog speaker delivers 360° high-fidelity sound with exceptional richness and depth. Its enveloping soundscape is born from the harmonious alliance of six ultra-precise active drivers and four finely tuned passive radiators, meticulously crafted to elevate the low frequencies. Every note fills the space with rare sensory intensity, transforming each moment into a deeply immersive listening experience. Packed with built-in microphones, it supports hands-free calls through your connected device, offering a fun and practical way to enjoy your Balloon Dog Speaker. Thanks to True Wireless Stereo (TWS) technology, two Balloon Dog Speakers can be paired to create an expansive stereo soundstage, offering greater depth, and a more powerful audio presence.
The Balloon Dog Lamp harnesses advanced multicolor lighting through nearly 400 integrated LEDs, delivering up to 200 lumens of brightness. It offers a wide selection of hues including warm and cold white, blue, magenta, green, orange, and more, allowing users to tailor the lighting to any setting. More than illumination, it offers a dynamic play of light, empowering users to shape the atmosphere and mood of any space with precision and elegance. With Lexon’s proprietary 'Easy Sync' technology, the Balloon Dog Lamp offers a next-level lighting experience, allowing you to connect and synchronize an infinite number of Balloon Dog Lamps in color and brightness effortlessly. Whether placed in different corners of a room or side by side for a striking visual effect, the Balloon Dog Lamps instantly sync together, creating a perfectly coordinated ambiance.
Both objects share the same sculptural dimensions of 11 inches / 28cm height and 2 pounds / 900 gr of technology are crafted for durability and everyday use. This collaboration merges artistic heritage with technological innovation, transforming an iconic artwork into functional design with purpose, presence, and everyday relevance.
“I’m excited about this new collaboration with Lexon, which has transformed Balloon Dog. The Balloon Dog Lamp has a wide range of vibrant colors, while the Balloon Dog Speaker surrounds us with immersive sound. The two objects are an exciting way for Balloon Dog to enter into our daily lives where art, design, and technology come together,” says Jeff Koons.
“Our creative alliance with Jeff Koons marks a historic moment for Lexon. It is both an honor and a milestone to bring together our passion for design and technology through a bold reimagining of Balloon Dog, one of the most iconic artworks of our time. This collaboration challenged us to go beyond form and function, crafting pieces that are not only innovative, but emotionally resonant; designed to be lived with, used daily, and cherished as true pieces of art. Through these two new Editions, we proudly reaffirm Lexon’s mission as a Maison de Design Française: to make timeless, high-quality design accessible to all, offering everyday objects that elevate life through beauty and purpose," says Boris Brault, CEO of Lexon.
Exclusive, Certified Authenticity
Each piece is engraved with Jeff Koons' signature under its front paws and comes with a certificate of authenticity. To further solidify its exclusivity, both the certificate and the packaging feature a hologram, reinforcing authentication and enhancing its collectible value. The Balloon Dog Speaker and Balloon Dog Lamp are produced in a limited supply, with pre-orders starting exclusively on lexon-design.com beginning June 17 2025. Shipping for pre-orders will start in October 2025.
An Immersive Journey Through Augmented Reality
To further elevate this artistic and technological experience, Lexon has unveiled an augmented reality (AR) feature that allows everyone to preview the Balloon Dog Lamp and Balloon Dog Speaker directly in their own space. This immersive tool enables users to visualize the pieces in real scale and context, bringing the essence of the collaboration into their homes and daily lives. By merging digital innovation with iconic design, the AR experience makes interacting with art more personal, accessible, and playful.
A Historic Collaboration with The Broad and The Shop at The Broad
As part of this collaboration, the Balloon Dog Speaker and Balloon Dog Lamp will be showcased for the first time at The Shop at The Broad on September 20, 2025, celebrating the museum’s 10th anniversary. The Broad, home to the original Balloon Dog sculpture, continues its mission to democratize art, making it accessible and meaningful beyond gallery walls. This partnership with Lexon enables the fusion of cutting-edge technology with iconic art, providing the public with a tangible, everyday connection to Koons' creations.
From September 20 to October 20 2025, the Balloon Dog Speaker and Balloon Dog Lamp will be available for an exclusive one-month sale at The Shop at The Broad, both in-store and online, offering visitors another unique opportunity to see and purchase these limited-edition pieces.
First Pre-order Details
- Pre-order Launch: June 17, 2025, starting exclusively on lexon-design.com
- Price: 750 $/€ per unit (Speaker or Lamp)
- Shipping Start: October 2025
- Pre-order Limits: 2 units per product, per customer
- Worldwide Availability: Pre-orders available internationally
About Lexon
Since its foundation in 1991, Lexon has relentlessly pushed boundaries and created a difference in the world of design, all while staying true to its commitment of making small objects useful, beautiful, innovative, and affordable. Whether in home, office, leisure, or travel accessories, Lexon has established a unique relationship with creativity and partnered with the best designers around the world to create timeless collections of lifestyle products, sold at million pieces every year. Today, with more than 30 years of existence, +250 awards, collaborations with some of the most renowned designers, a retail presence in 90 countries across the Globe, Lexon has truly established itself as an iconic French design brand.
About Jeff Koons
Jeff Koons is a leading contemporary artist known for transforming everyday objects into bold, reflective sculptures that engage with art history and modern culture. Born in 1955 in York, Pennsylvania, he studied at the Maryland Institute College of Art and the School of the Art Institute of Chicago. Since his first solo exhibition in 1980, his work has been showcased globally in major institutions like MoMA, the Guggenheim, and Tate and of course, The Broad. Koons' iconic pieces, including Balloon Dog, Rabbit, and Puppy, explore themes of self-acceptance and transcendence. His monumental floral sculptures and mirror-finished stainless steel works challenge perceptions of materiality and craftsmanship. Honored internationally, Koons has received the Légion d’Honneur from France and the U.S. Department of State’s Medal of the Arts. He has also contributed to cultural diplomacy and child protection efforts through the Koons Family International Law and Policy Institute.
About The Broad
The Broad’s mission is to make contemporary art accessible to the widest possible audience. Founded in 2015 on Grand Avenue in downtown Los Angeles by philanthropists Eli and Edythe Broad, the museum offers free general admission and presents an active program of special exhibitions and innovative live events, all within a landmark building designed by Diller Scofidio + Renfro. The Broad is home to the Broad collection, one of the world’s leading collections of postwar and contemporary art, which continues to grow as new artists and artworks are added. The museum is the headquarters of The Broad Art Foundation’s worldwide lending library, which has been loaning collection works to museums around the world since 1984. An expansion of the museum will open before the 2028 summer Olympics in Los Angeles, creating even greater public access.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610649262/en/
Contacts
Annabel Corlay
a.corlay@lexon-design.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom